Xvivo Perfusion AB (publ) (STO:XVIVO)

Market Cap	14.44B
Revenue (ttm)	822.42M
Net Income (ttm)	172.18M
Shares Out	31.50M
EPS (ttm)	5.44
PE Ratio	84.28
Forward PE	86.92
Dividend	n/a
Ex-Dividend Date	n/a

Volume	40,789
Average Volume	60,740
Open	463.00
Previous Close	463.50
Day's Range	457.50 - 468.00
52-Week Range	252.50 - 547.00
Beta	2.09
RSI	46.84
Earnings Date	Jan 28, 2025

About Xvivo Perfusion AB

Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden, the United States, the Netherlands, Italy, North and South America, Europe, the Middle East, Africa, the Asia Pacific, and Oceania. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a c...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 170
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: XVIVO

Financial Performance

In 2024, Xvivo Perfusion AB's revenue was 822.42 million, an increase of 37.63% compared to the previous year's 597.54 million. Earnings were 172.18 million, an increase of 87.52%.